1Department of Biology, Federal University of Maranhão, São Luís, Brazil.
2State University of Maranhão, Caxias, Brazil.
Am J Trop Med Hyg. 2020 Sep;103(3):1076-1080. doi: 10.4269/ajtmh.20-0131.
Diffuse cutaneous leishmaniasis (DCL) is a rare type of leishmaniasis characterized by diffuse skin lesions. In Brazil, () is the main etiological agent of this clinical form. The state of Maranhão has the highest prevalence of this disease in the country, as well as a high rate of HIV infection. Here, we report the first case of DCL/HIV of Brazil. A 46-year-old man from the Amazonian area of Maranhão state presented atypical lesion in the left upper limb and dissemination of diffuse erythematous nodules over his entire body. Histopathological examination confirmed the presence of intracellular amastigotes of , and a polymerase chain reaction and molecular identification by restriction fragment profile identified () as the causative agent of the disease. The patient was also diagnosed with HIV virus after the leishmaniasis diagnosis. The initial treatments for leishmaniasis were liposomal amphotericin B (AmB-L) (4 mg/kg) for 10 days and prophylactic use of Glucantime (10 mg/Sb/kg) for 2 months. After unsuccessful initial treatments, he was treated with a combination of AmB-L (4 mg/kg) alternated with pentamidine (4 mg/kg) for 10 days but failed in the first therapeutic cycle. Subsequently, he had a good response to treatment with pentamidine (4 mg/kg).
弥漫性皮肤利什曼病(DCL)是一种罕见的利什曼病类型,其特征为皮肤弥漫性病变。在巴西,()是这种临床形式的主要病因。马拉尼昂州是该国该病发病率最高的州,同时 HIV 感染率也很高。在这里,我们报告了巴西首例 DCL/HIV 病例。一名来自马拉尼昂州亚马逊地区的 46 岁男子,上肢出现非典型病变,全身散布弥漫性红斑性结节。组织病理学检查证实存在()的内体阿米巴原虫,聚合酶链反应和分子鉴定通过限制片段谱确定()为疾病的病原体。该患者在诊断出利什曼病后还被诊断出 HIV 病毒。最初的利什曼病治疗方案为 10 天内每天给予 4 毫克/千克两性霉素 B 脂质体(AmB-L)和 2 个月内预防性给予 Glucantime(10 毫克/ Sb/kg)。初始治疗失败后,他接受了 AmB-L(4 毫克/千克)与戊烷脒(4 毫克/千克)交替使用 10 天的联合治疗,但在第一个治疗周期中失败。随后,他对戊烷脒(4 毫克/千克)治疗有良好的反应。